Dolly A. Vance
2014
In 2014, Dolly A. Vance earned a total compensation of $1.1M as Executive Vice President, Corporate Affairs, General Counsel and Corporate Secretary at Rigel Pharmaceuticals.
Compensation breakdown
| Option Awards | $653,575 |
|---|---|
| Salary | $475,548 |
| Other | $3,042 |
| Total | $1,132,165 |
Vance received $653.6K in option awards, accounting for 58% of the total pay in 2014.
Vance also received $475.5K in salary and $3K in other compensation.
Rankings
In 2014, Dolly A. Vance's compensation ranked 7,033rd out of 13,032 executives tracked by ExecPay. In other words, Vance earned more than 46.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,033 out of 13,032 | 46th |
Division Manufacturing | 2,587 out of 4,966 | 48th |
Major group Chemicals And Allied Products | 880 out of 1,686 | 48th |
Industry group Drugs | 693 out of 1,365 | 49th |
Industry Pharmaceutical Preparations | 530 out of 1,043 | 49th |
Source: SEC filing on March 29, 2017.
Vance's colleagues
We found five more compensation records of executives who worked with Dolly A. Vance at Rigel Pharmaceuticals in 2014.
2014
James Gower
Rigel Pharmaceuticals
Chief Executive Officer
2014
Donald Payan
Rigel Pharmaceuticals
Executive Vice President, of Discovery and Research
2014
Raul Rodriguez
Rigel Pharmaceuticals
Chief Executive Officer
2014
Elliott Grossbard
Rigel Pharmaceuticals
Chief Medical Officer
2014
Ryan Maynard
Rigel Pharmaceuticals